Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study

MLA

Cibula, David, et al. “Role of Adjuvant Therapy in Intermediate-Risk Cervical Cancer Patients – Subanalyses of the SCCAN Study.” Gynecologic Oncology, vol. 170, Mar. 2023, pp. 195–202. EBSCOhost, https://doi.org/10.1016/j.ygyno.2023.01.014.

APA

Cibula, D., Akilli, H., Jarkovsky, J., van Lonkhuijzen, L., Scambia, G., Meydanli, M. M., Ortiz, D. I., Falconer, H., Abu-Rustum, N. R., Odetto, D., Klát, J., dos Reis, R., Zapardiel, I., di Martino, G., Presl, J., Laky, R., López, A., Weinberger, V., Obermair, A., … Ayhan, A. (2023). Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study. Gynecologic Oncology, 170, 195–202. https://doi.org/10.1016/j.ygyno.2023.01.014

Chicago

Cibula, David, Huseyin Akilli, Jiri Jarkovsky, Luc van Lonkhuijzen, Giovanni Scambia, Mehmet Mutlu Meydanli, David Isla Ortiz, et al. 2023. “Role of Adjuvant Therapy in Intermediate-Risk Cervical Cancer Patients – Subanalyses of the SCCAN Study.” Gynecologic Oncology 170 (March): 195–202. doi:10.1016/j.ygyno.2023.01.014.